Semaglutide 2.4 mg: the latest GLP-1RA approved for obesity

Journal of Investigative Medicine ◽

10.1136/jim-2021-002227 ◽

2021 ◽

Vol 70 (1) ◽

pp. 3-4

Author(s):

Ricardo Villela ◽

Ricardo Correa

Download Full-text